Icariin suppresses osteogenic differentiation and promotes bone regeneration in Porphyromonas gingivalis-infected conditions through EphA2-RhoA signaling pathway
International Immunopharmacology · 2024-12 · 143 · 113302
DOI: 10.1016/j.intimp.2024.113302 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024-12. Verfasst von Wei Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Jinzhou Medical University, Jinzhou 121000, China. Hauptthemen laut MEDLINE: Porphyromonas gingivalis, Osteogenesis, Flavonoids, Signal Transduction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Beijing Xisike Clinical Oncology Research Foundation.
Abstract (Originalsprache)
Periodontitis is associated with multiple systemic diseases and can cause bone loss. Porphyromonas gingivalis (P. gingivalis) is one of the most virulent periodontal pathogens. Icariin is a flavonoid extracted from the traditional Chinese herbal medicine Herba Epimedii, and can regulate bone metabolism. However, its effects on promoting bone metabolism have not been fully elucidated. In this experiment, we infected MC3T3-E1 cells with P. gingivalis. Flow cytometry results show that persistent bacterial infection does not affect cell proliferative activity. Western blotting, ALP activity detection, mineral content determination, and immunofluorescence blotting confirmed that icariin improved osteogenic differentiation in the inflammatory state, and this effect may be more obvious in the early stage of osteogenic differentiation. The antibacterial assays, ROS and MMP fluorescence assays demonstrated that icariin exerted a significant inhibitory effect on bacterial growth and attenuated the inflammatory response in bacterial-infected conditions. The results of in vivo experiments in animals further validated the excellent properties exerted by icariin in the repair of bone defects. Additionally, in the P. gingivalis-infected state, icariin exert a regulatory effect on EphA2-RhoA signaling pathway to augment osteogenic differentiation. These exciting findings suggest that icariin holds significant potential for therapeutic application in the management of periodontal bone loss.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jinzhou Medical University, Jinzhou 121000, China.
- The First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121000, China. Electronic address: wenlu5460@126.com.
Förderung
- Beijing Xisike Clinical Oncology Research Foundation
Zitieren
APA
Wang, W., Sun, D. F., Dong, Z., & Zhang, W. L. (2024). Icariin suppresses osteogenic differentiation and promotes bone regeneration in Porphyromonas gingivalis-infected conditions through EphA2-RhoA signaling pathway. International Immunopharmacology, 143, 113302. https://doi.org/10.1016/j.intimp.2024.113302
Vancouver
Wang W, Sun DF, Dong Z, Zhang WL. Icariin suppresses osteogenic differentiation and promotes bone regeneration in Porphyromonas gingivalis-infected conditions through EphA2-RhoA signaling pathway. International Immunopharmacology. 2024;143:113302. doi:10.1016/j.intimp.2024.113302
BibTeX
@article{Wang2024,
author = {Wang, Wei and Sun, Dan-Fang and Dong, Zhe and Zhang, Wen-Lu},
title = {Icariin suppresses osteogenic differentiation and promotes bone regeneration in Porphyromonas gingivalis-infected conditions through EphA2-RhoA signaling pathway},
journal = {International Immunopharmacology},
year = {2024},
volume = {143},
pages = {113302},
doi = {10.1016/j.intimp.2024.113302}
}
EUVIMED